Early Day List To Watch: Adept Technology Inc. (NASDAQ:ADEP), Agile Therapeutics (NASDAQ:AGRX), Preferred Bank (NASDAQ:PFBC), Amerisafe (NASDAQ:AMSF), DaVita HealthCare Partners Inc. (NYSE:DVA)


Adept Technology Inc. (NASDAQ:ADEP) shares increased 3.35% in last trading session and ended the day at $7.10. ADEP Gross Margin is 44.00% and its has a return on assets of -13.50%. Adept Technology Inc. (NASDAQ:ADEP) quarterly performance is 13.60%.

Adept Technology, Inc. (Adept) is a robotics-based automation supplier. The Company designs and manufactures industrial and mobile robots along with a complementary suite of control and vision systems and software which are used for assembly, packaging, handling, testing and logistics applications in both fixed repetitive and unstructured environments.

Adept Technology Inc. (NASDAQ:ADEP) announced its fiscal 2015 fourth quarter and full year financial results. Released the Hornet 565, a new high-speed, competitively priced packaging robot. Revenues for the fourth quarter of fiscal 2015 were $13.9 million, compared with $14.3 million in 2014. Excluding the impact of changes in foreign currency rates, revenue increased 8% in the quarter. Gross margin was 39.0%, compared with 46.3% in 2014. Excluding the impacts of changes in foreign currency rates, gross margin declined 280 basis points in the quarter.

Agile Therapeutics, Inc. (NASDAQ:AGRX) ended the last trading day at $8.83. Company weekly volatility is calculated as 6.05% and price to cash ratio as 19.43. Agile Therapeutics, Inc. (NASDAQ:AGRX) showed a weekly performance of 9.01%.

Agile Therapeutics, Inc. is a women’s health specialty pharmaceutical company. The Company is engaged in the development and commercialization of prescription contraceptive products. The Company’s product candidates are designed to provide women with contraceptive options.

Agile Therapeutics, Inc. (NASDAQ:AGRX) announced that active recruitment has closed in its ongoing single-arm, open-label Phase 3 SECURE clinical trial of Twirla(R) (AG200-15), its investigational contraceptive patch. Participating sites will complete screening over the next two weeks, and the Company expects to complete enrollment by the end of the third quarter 2015.

On 31 August, Preferred Bank (NASDAQ:PFBC) shares remains unchanged and was closed at $30.65. Preferred Bank (NASDAQ:PFBC) year to date (YTD) performance is 9.90%.

PREFERRED BANK is a commercial bank based in Southern California. The Bank provides personalized deposit services as well as real estate finance, commercial loans and trade finance to small and mid-sized businesses and their owners, entrepreneurs, real estate developers and investors, professionals and high net worth individuals.

Preferred Bank (NASDAQ:PFBC), announced that Nick Pi has been named as permanent Chief Credit Officer. On June 17 of this year, Mr. Pi was appointed as Acting Chief Credit Officer and has been with Preferred Bank as Executive Vice President and Group Manager since 2003.

Amerisafe, Inc. (NASDAQ:AMSF) shares moved down -0.36% in last trading session and ended the day at $46.74. AMSF has a return on assets of 4.00%. Amerisafe, Inc. (NASDAQ:AMSF) quarterly performance is 8.45%.

AMERISAFE, Inc. (AMERISAFE) is an insurance holding company. The Company is a provider of workers’ compensation insurance focused on small to mid-sized employers engaged in hazardous industries, including construction, trucking, manufacturing, oil and gas and agriculture.

Amerisafe, Inc. (NASDAQ:AMSF) announced that Neal Fuller will become Chief Financial Officer effective September 15, 2015. Mr. Fuller has more than 24 years of experience in the insurance industry who served in multiple leadership positions with Safeco Corporation from 1988 to 2009, ending as Senior Vice President – Finance and Treasurer. Most recently, Mr. Fuller served as Senior Vice President and Chief Financial Officer of ICW Group and Senior Vice President and Chief Financial Officer of SeaBright Holdings, Inc.

DaVita Kidney care, a division of DaVita HealthCare Partners Inc. (NYSE:DVA) announced it is forming a joint venture kidney care specialty hospital chain in Shandong province China. The agreement establishes DaVita (Shandong) Kidney Disease Hospital Co., Ltd., a first-of-its-kind renal dialysis joint venture between a multinational health care provider and the private sector in China.
DaVita HealthCare Partners Inc. consists of two divisions, Kidney Care and HealthCare Partners (HCP). Kidney Care is a provider of dialysis services in the United States, treating patients with chronic kidney failure and end stage renal disease (ESRD).
DaVita HealthCare Partners Inc. (NYSE:DVA) caters to the Healthcare space. It has a net profit margin of 3.40% and weekly performance is 2.11%. On the last day of trading company shares ended up $75.64. DaVita HealthCare Partners Inc. (NYSE:DVA) distance from 50-day simple moving average (SMA50) is -4.75%.


Leave a Reply

Your email address will not be published. Required fields are marked *